Skip to main content
. Author manuscript; available in PMC: 2023 Apr 1.
Published in final edited form as: Arthritis Rheumatol. 2022 Mar 10;74(4):612–622. doi: 10.1002/art.42001

Table 1.

Cohort characteristics for all subjects and stratified by baseline knee OA status

Baseline Demographics MOST Chingford JoCoOA Framingham HCS TaSOAC
Follow-up period 5 years 9 years 7 years 7 years 12 years 5 years
Original N 3026 1003 2754 1166 1412 1100
ROA OA-related Knee Pain PROA ROA OA-related Knee Pain PROA ROA OA-related Knee Pain PROA ROA OA-related Knee Pain PROA ROA OA-related Knee Pain PROA ROA OA-related Knee Pain PROA
N 1078 1102 1,518 681 556 756 997 795 1213 759 629 789 337 243 - - 452 -
Knee OA outcome at follow-up, n (%) 262 (24.3) 322 (29.2) 308 (20.3) 190 (27.9) 65 (11.7) 48 (6.4) 255 (25.6) 131 (16.5) 132 (10.9) 70 (9.2) 116 (18.4) 48 (6.1) 114 (33.8) 21 (8.6) - - 60 (13.3) -
MET days/week, median (IQR) 1.2 (0.6–1.9) 1.1 (0.6–1.9) 1.1 (0.6–1.9) 0 (0–0.5) 0 (0–0.5) 0 (0–0.5) 0.3 (0.0–0.8) 0.3 (0.1–0.8) 0.3 (0.0–0.8) 11.4 (8.7–14.4) 11.4 (8.7–14.4) 11.3 (8.4–14.3) 0.2 (0–0.5) 0.2 (0–0.5) - - 1.4 (0.3–2.8) -
Age (years), mean (48) 60.5 (7.7) 62.3 (7.9) 61.6 (7.9) 53.5 (5.8) 53.8 (5.9) 53.7 (5.9) 60.7 (8.5) 61.9 (9.3) 61.7 (9.0) 51.9 (8.7) 51.9 (8.7) 51.9 (8.7) 64.7 (2.7) 64.8 (2.8) - - 62.0 (7.0) -
Sex, n (% Female) 638 (59.2) 608 (55.2) 890 (58.6) 681 (100) 556 (100) 756 (100) 673 (67.5) 507 (63.8) 802 (66.1) 427 (56.3) 348 (55.3) 442 (56.0) 170 (50.5) 117 (48.2) - - 219 (48.5) -
Race, n (%)
 Caucasian 945 (87.7) 969 (87.9) 1325 (87.3) 681 (100) 556 (100) 756 (100) 731 (73.3) 577 (72.6) 879 (72.5) 759 (100) 629 (100) 789 (100) 337 (100) 243 (100) - - 446 (98.7) -
 African American 117 (10.8) 118 (10.7) 169 (11.1) - - - 266 (26.7) 218 (27.4) 334 (27.5) - - - - - - - - -
 Chinese - - - - - - - - - - - - - - - - - -
 Other 16 (1.5) 15 (1.4) 24 (1.6) - - - - - - - - - - - - - 6 (1.3) -
BMI (kg/m2), mean (48) 29.1 (4.7) 29.6 (4.8) 29.5 (5.0) 25.1 (3.9) 25.0 (3.9) 25.3 (4.0) 29.4 (5.5) 29.5 (5.8) 29.6 (5.8) 27.0 (4.8) 26.8 (4.6) 27.1 (4.8) 26.5 (4.0) 26.3 (4.0) - - 27.2 (4.2) -
*

Subjects not having knee osteoarthritis outcome at baseline, not having rheumatoid arthritis, not missing knee osteoarthritis data at baseline or follow-up, not missing PA, age, sex, race, BMI data